biomea fusion
Erik Rasmussen has a strong background in clinical data management, holding various leadership positions in different pharmaceutical companies such as Biomea Fusion, Summit Therapeutics, Alector, AbbVie, and Pharmacyclics. With experience dating back to 2003 at companies like Clinimetrics and Clinovo, Erik has developed a wealth of expertise in managing clinical data effectively.
biomea fusion
Biomea Fusion, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was formed in 2017 by a small group of biotech executives that came together with the common goal of achieving better therapies for patients.